6919.TWO
Price:
$167
Market Cap:
$25.62B
Caliway Biopharmaceuticals Co.Ltd develops small molecule drugs for medical aesthetic and inflammatory disease. The company was founded in 2012 and is based in New Taipei City, Taiwan.
Industry
Biotechnology
IPO Date
2022-12-26
Stock Exchange
TWO
Ticker
6919.TWO
According to Caliway Biopharmaceuticals Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -6.44%. This represents a change of 297.77% compared to the average of -1.62% of the last 4 quarters.
The mean historical ROE of Caliway Biopharmaceuticals Co., Ltd. over the last ten years is 169.89%. The current -6.44% ROE has changed -103.79% with respect to the historical average. Over the past ten years (40 quarters), 6919.TWO's ROE was at its highest in in the December 2024 quarter at -0.58%. The ROE was at its lowest in in the June 2023 quarter at -18.15%.
Average
169.89%
Median
-18.82%
Minimum
-211.36%
Maximum
1.31%
Discovering the peaks and valleys of Caliway Biopharmaceuticals Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 1.31%
Minimum Annual Increase = -116.14%
Minimum Annual ROE = -211.36%
| Year | ROE | Change |
|---|---|---|
| 2024 | -6.07% | -53.49% |
| 2023 | -13.06% | -46.88% |
| 2022 | -24.58% | -29.36% |
| 2021 | -34.79% | -83.54% |
| 2020 | -211.36% | -116.14% |
The current ROE of Caliway Biopharmaceuticals Co., Ltd. (6919.TWO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-14.57%
5-year avg
-57.97%
10-year avg
169.89%
Caliway Biopharmaceuticals Co., Ltd.’s ROE is greater than Pell Bio-Med Technology Co., Ltd. (-30.90%), less than Sunmax Biotechnology Co., Ltd. (53.42%), greater than Lin BioScience, Inc. (-24.96%), greater than EirGenix Inc. (-10.02%), greater than TaiMed Biologics Inc. (-6.05%), greater than Polaris Group (-52.87%), greater than Center Laboratories, Inc. (-3.67%), greater than Tanvex BioPharma, Inc. (-45.02%), greater than Oneness Biotech Co., Ltd. (-16.08%), less than TTY Biopharm Company Limited (25.06%),
| Company | ROE | Market cap |
|---|---|---|
| -30.90% | $21.79B | |
| 53.42% | $21.40B | |
| -24.96% | $34.33B | |
| -10.02% | $22.54B | |
| -6.05% | $17.87B | |
| -52.87% | $22.34B | |
| -3.67% | $27.05B | |
| -45.02% | $15.52B | |
| -16.08% | $27.99B | |
| 25.06% | $20.74B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Caliway Biopharmaceuticals Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Caliway Biopharmaceuticals Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Caliway Biopharmaceuticals Co., Ltd.'s ROE?
How is the ROE calculated for Caliway Biopharmaceuticals Co., Ltd. (6919.TWO)?
What is the highest ROE for Caliway Biopharmaceuticals Co., Ltd. (6919.TWO)?
What is the 3-year average ROE for Caliway Biopharmaceuticals Co., Ltd. (6919.TWO)?
What is the 5-year average ROE for Caliway Biopharmaceuticals Co., Ltd. (6919.TWO)?
How does the current ROE for Caliway Biopharmaceuticals Co., Ltd. (6919.TWO) compare to its historical average?